Cell adhesion and angiogenesis

Journal of Clinical Investigation

Volumn 99, Issue 3, 1997, Pages 373-376

  Bischoff, Joyce ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ARGINYLGLYCYLASPARTIC ACID; CADHERIN; CD31 ANTIGEN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN; INTEGRIN; PROTEIN P21; PROTEIN P53; SELECTIN; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; CHEMOTAXIS; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030821648     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119168     Document Type: Review

References (27)

1. Folkman, J. 1971. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285:1182-1186.
2. Folkman, J. 1995. Clinical applications of research on angiogenesis. N. Engl. J. Med. 333:1757-1763.
3. Hirschi, K.K., and P.A. D'Amore. 1996. Pericytes in the microvasculature. Cardiovasc. Res. 32:687-698.
4. Folkman, J., and A. Moscona. 1978. Role of cell shape in growth control. Nature (Lund.). 273:345-349.
5. Ingber, D.E. 1990. Fibronectin controls capillary endothelial cell growth by modulating cell shape. Proc. Natl. Acad. Sci. USA. 87:3579-3583.
6. Meredith, J.E., B. Fazeli, and M.A. Schwanz. 1993. The extracellular matrix as a cell survival factor. Mol. Biol. Cell. 4:953-961.
7. Luscinskas, F.W., and J. Lawler. 1994. Integrins as dynamic regulators of vascular function. FASEB (Fed. Am. Soc. Exp. Biol.) J. 8:929-938.
8. Piali, L., P. Hammel, C. Uherek, F. Bachmann, R.H. Gisler, D. Dunon, and B.A. Imhof. 1995. CD31/PECAM-1 is a ligand for alpha-v/beta-3 integrin involved in adhesion of leukocytes to endothelium. J. Cell Biol. 130:451-460.
9. Brooks, P.C., S. Stromblad, L.C. Sanders, T.L. von Schalscha, R.T. Aimes, W.G. Stetler-Stevenson, J.P. Ouigley, and D.A. Cheresh. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha-v/heta-3. Cell. 85:683-693.
10. Brooks, P.C., R.A.F. Clark, and D.A. Cheresh. 1994. Requirement of vascular integrin alpha-v/beta-3 for angiogenesis. Science (Wash. DC). 264:569-571.
11. Brooks, P.C., A.M.P. Montgomery, M. Rosenfeld, R.A. Reisfeld. T. Hu, G. Klier, and D.A. Cheresh. 1994. Integrin alpha-v/beta-3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 79: 1157-1164.
12. Hammes, H.P., M. Brownlee, A. Jonczyk, A. Sutter, and K.T. Preissner. 1996. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat. Med. 2:529-533.
13. Friedlander, M., P.C. Brooks, R.W. Shaffer, C.M. Kincaid, J.A. Varner, and D.A. Cheresh. 1995. Definition of two angiogenic pathways by distinct alpha-v integrins. Science (Wash. DC). 270:1500-1502.
14. Drake, C.J., D.A. Cheresh, and C.D. Little. 1995. An antagonist of integrin alpha-v/beta-3 prevents maturation of blood vessels during embryonic neovascularization. J. Cell. Sci. 108:2655-2661.
15. WAF1/C1P1 expression by vascular cell integrin αvβ3 during angiogenesis. J. Clin. Invest. 98:426-433.
16. Alon, T., I. Hemo, A. Itin, J. Pe'Er, J. Stone, and E. Keshet. 1995. Vascular endothelial growth factor acts as a survival factor for newly formed etinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1:1024-1028.
17. Breier, G., F. Breviario, L. Caveda, R. Berthier, H. Schnurch, U. Gotsch, D. Vestweber, W. Risau, and E. Dejana. 1996. Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of the cardiovascular system. Blood. 87:630-641.
18. Dejana, E. 1996. Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J. Clin. Invest. 98:1949-1953.
19. Berger, R., S.M. Albelda, D. Berd, M. loffreda, D. Whitaker, and G.F. Murphy. 1993. Expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) during melanoma-induced angiogenesis in vivo. J. Cutan. Pathol. 20:399-406.
20. Nguyen, M., N.A. Strubel, and J. Bischoff. 1993. A role for sialyl Lewis-x/a glycoconjugates in capillary morphogenesis. Nature (Lond.). 365:267-269.
21. Nguyen, M., J. Folkman, and J. Bischoff. 1992. 1-Deoxymannojirimycin inhibits capillary tube formation in vitro. J. Biol. Chem. 267:26157-26165.
22. Nguyen, M., F.R. Eilber, and S. Defrees. 1996. Novel synthetic analogs of sialyl Lewis X can inhibit angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun. 228:716-723.
23. Kraling, B.M., M.J. Razon, L.M. Boon, D. Zurakowski, C. Seachord, R.P Darveau, J.B. Mulliken, C.L. Corless, and J. Bischoff. 1996. E-Selectin is present in proliferating endothelial cells in human hemangiomas. Am. J. Pathol. 148:1181-1191.
24. Koch, A.E., M.M. Halloran, C.J. Haskell, M.R. Shah, and P.J. Polverini. 1995. Angiogenesis is mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature (Lond.). 376:517-519.
25. Labow, M.A., C.R. Norton, J.M. Rumberger, K.M. Lombard-Gillooly, D.J. Shuster, J. Hubbard, R. Bertko, P.A. Knaack, R.W. Terry, M.L. Harbison, et al. 1994. Characterization of E-selectin-deficient mice: demonstration of overlapping function of the endothelial selectins. Immunology. 1:709-720.
26. Frenette, P.S., T.N. Mayadas, H. Rayburn, R.O. Hynes, and D.D. Wagner. 1996. Susceptibility to infection and altered hematopoiesis in mice deficient in both P-and E-selectins. Cell. 84:563-574.
27. Gerritsen, M.E., C.-P. Shen, W.J. Atkinson, R.C. Padgett, M.A. Gimbrone, and D.S. Milstone. 1996. Microvascular endothelial cells from E-selectin-deficient mice form tubes in vitro. Lab. Invest. 75:175-184.